ICP
WST icon

Interchange Capital Partners’s West Pharmaceutical WST Stock Holding History

Interchange Capital Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$259K Buy
+722
New +$221K 0.05% 340
2021
Q1 		– Sell
-1,043
Closed -$295K – 1116
2020
Q4 		$295K Buy
+1,043
New +$293K 0.16% 154

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Interchange Capital Partners's WST Position: Q2 2026 in Review

Interchange Capital Partners opened a new position in West Pharmaceutical (WST) in Q2 2026: 722 shares worth $259K. The stake represents 0.05% of the portfolio and ranks #340 among its holdings. This is a return to the name: Interchange Capital Partners previously reported a position in WST as recently as Q4 2020.

Interchange Capital Partners first reported a position in WST in Q4 2020 and has held it in 2 quarters since. The position peaked at $295K in Q4 2020. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Interchange Capital Partners held 722 shares of West Pharmaceutical worth $259K as of Q2 2026.
  • West Pharmaceutical was a new Interchange Capital Partners position in Q2 2026.
  • West Pharmaceutical made up 0.05% of Interchange Capital Partners's portfolio in Q2 2026, its #340 holding.
  • Interchange Capital Partners first reported a position in West Pharmaceutical in Q4 2020 and has held it in 2 quarters since.
  • Interchange Capital Partners's West Pharmaceutical position peaked at $295K in Q4 2020.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Interchange Capital Partners's 13F filing for Q2 2026, filed 20 Jul 2026.